TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 278 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2022. The put-call ratio across all filers is 0.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,003 | -99.9% | 62,103 | -1.8% | 0.01% | +14.3% |
| Q3 2022 | $796,000 | -8.3% | 63,248 | +6.7% | 0.01% | 0.0% |
| Q2 2022 | $868,000 | -1.8% | 59,264 | -1.7% | 0.01% | +16.7% |
| Q1 2022 | $884,000 | -1.6% | 60,262 | -2.6% | 0.01% | -14.3% |
| Q4 2021 | $898,000 | -5.0% | 61,849 | -7.9% | 0.01% | +16.7% |
| Q3 2021 | $945,000 | -70.4% | 67,150 | -65.1% | 0.01% | -68.4% |
| Q2 2021 | $3,191,000 | -2.7% | 192,339 | +0.1% | 0.02% | -5.0% |
| Q1 2021 | $3,278,000 | -2.6% | 192,099 | +3.4% | 0.02% | -4.8% |
| Q4 2020 | $3,367,000 | +12.9% | 185,727 | +3.8% | 0.02% | -4.5% |
| Q3 2020 | $2,982,000 | -5.2% | 178,968 | -0.8% | 0.02% | -8.3% |
| Q2 2020 | $3,145,000 | +4.8% | 180,322 | +5.5% | 0.02% | -14.3% |
| Q1 2020 | $3,001,000 | -13.5% | 170,925 | -3.4% | 0.03% | +7.7% |
| Q4 2019 | $3,468,000 | +11.0% | 176,875 | -0.2% | 0.03% | +4.0% |
| Q3 2019 | $3,125,000 | -1.8% | 177,302 | -3.1% | 0.02% | 0.0% |
| Q2 2019 | $3,182,000 | -13.6% | 182,977 | -1.5% | 0.02% | -16.7% |
| Q1 2019 | $3,681,000 | +85.3% | 185,800 | +88.9% | 0.03% | +76.5% |
| Q4 2018 | $1,987,000 | – | 98,373 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Adelphi Capital LLP | 9,270,535 | $188,841,000 | 39.13% |
| Sachem Head Capital | 5,963,600 | $121,479,000 | 7.38% |
| NINE MASTS CAPITAL Ltd | 1,049,886 | $21,415,000 | 6.68% |
| Paulson & Co. | 26,489,422 | $539,590,000 | 5.77% |
| Blackcrane Capital, LLC | 189,549 | $3,861,000 | 5.16% |
| Glenview Capital Management | 26,112,660 | $531,915,000 | 4.75% |
| Exane Asset Management | 430,369 | $8,766,617,000 | 4.26% |
| Velanne Asset Management Ltd | 281,972 | $5,744,000 | 3.97% |
| Bluefin Trading, LLC | 1,204,702 | $24,540,000 | 3.55% |
| Endurant Capital Management LP | 437,436 | $8,911,000 | 3.52% |